Article
Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 May 2008
El-Zein Randa A, Fenech Michael, Lopez Mirtha S, Spitz Margaret R, Etzel Carol J
Abstract excerpt
The multi-endpoint cytokinesis-blocked micronucleus assay is used for assessing chromosome aberrations. We have recently reported that this assay is extremely sensitive to genetic damage caused by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and that the binucleated cells with micronuclei, nucleoplasmic bridges, and nuclear buds in lymphocytes (chromosome damage endpoints...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
